169 related articles for article (PubMed ID: 34533595)
1. Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study.
Smit MA; van Pelt GW; Terpstra V; Putter H; Tollenaar RAEM; Mesker WE; van Krieken JHJM
Int J Colorectal Dis; 2021 Dec; 36(12):2729-2737. PubMed ID: 34533595
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study.
Eriksen AC; Sørensen FB; Lindebjerg J; Hager H; dePont Christensen R; Kjær-Frifeldt S; Hansen TF
Int J Colorectal Dis; 2018 Aug; 33(8):1115-1124. PubMed ID: 29785462
[TBL] [Abstract][Full Text] [Related]
3. Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
Eriksen AC; Andersen JB; Lindebjerg J; dePont Christensen R; Hansen TF; Kjær-Frifeldt S; Sørensen FB
Diagn Pathol; 2018 Mar; 13(1):20. PubMed ID: 29558947
[TBL] [Abstract][Full Text] [Related]
4. Tumour Budding and Tumour Stroma Ratio are Reliable Predictors for Death and Recurrence in Elderly Stage I Colon Cancer Patients.
Zengin M
Pathol Res Pract; 2019 Nov; 215(11):152635. PubMed ID: 31564570
[TBL] [Abstract][Full Text] [Related]
5. A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance.
Strous MTA; Faes TKE; Gubbels ALHM; van der Linden RLA; Mesker WE; Bosscha K; Bronkhorst CM; Janssen-Heijnen MLG; Vogelaar FJ; de Bruïne AP
Clin Transl Oncol; 2022 Jun; 24(6):1047-1058. PubMed ID: 35064453
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumour budding, tumour-stroma ratio and desmoplastic stromal reaction in gall bladder carcinoma.
Goyal S; Banga P; Meena N; Chauhan G; Sakhuja P; Agarwal AK
J Clin Pathol; 2023 May; 76(5):308-314. PubMed ID: 34853164
[TBL] [Abstract][Full Text] [Related]
7. The tumour-stroma ratio in colon cancer: the biological role and its prognostic impact.
van Pelt GW; Sandberg TP; Morreau H; Gelderblom H; van Krieken JHJM; Tollenaar RAEM; Mesker WE
Histopathology; 2018 Aug; 73(2):197-206. PubMed ID: 29457843
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of the tumor-stroma ratio in squamous cell lung cancer, a cohort study.
Smit MA; Philipsen MW; Postmus PE; Putter H; Tollenaar RA; Cohen D; Mesker WE
Cancer Treat Res Commun; 2020; 25():100247. PubMed ID: 33249210
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of tumour-stroma ratio in early-stage oral tongue cancers.
Almangush A; Heikkinen I; Bakhti N; Mäkinen LK; Kauppila JH; Pukkila M; Hagström J; Laranne J; Soini Y; Kowalski LP; Grénman R; Haglund C; Mäkitie AA; Coletta RD; Leivo I; Salo T
Histopathology; 2018 Jun; 72(7):1128-1135. PubMed ID: 29427291
[TBL] [Abstract][Full Text] [Related]
10. e-Learning for Instruction and to Improve Reproducibility of Scoring Tumor-Stroma Ratio in Colon Carcinoma: Performance and Reproducibility Assessment in the UNITED Study.
Smit MA; van Pelt GW; Dequeker EM; Al Dieri R; Tollenaar RA; van Krieken JHJ; Mesker WE;
JMIR Form Res; 2021 Mar; 5(3):e19408. PubMed ID: 33739293
[TBL] [Abstract][Full Text] [Related]
11. Tumour budding and tumour-stroma ratio in hepatocellular carcinoma.
Kairaluoma V; Kemi N; Pohjanen VM; Saarnio J; Helminen O
Br J Cancer; 2020 Jul; 123(1):38-45. PubMed ID: 32362654
[TBL] [Abstract][Full Text] [Related]
12. Prognostication for oral squamous cell carcinoma patients based on the tumour-stroma ratio and tumour budding.
Dourado MR; Miwa KYM; Hamada GB; Paranaíba LMR; Sawazaki-Calone Í; Domingueti CB; Ervolino de Oliveira C; Furlan ECB; Longo BC; Almangush A; Salo T; Coletta RD
Histopathology; 2020 May; 76(6):906-918. PubMed ID: 31984527
[TBL] [Abstract][Full Text] [Related]
13. Tumor-stroma ratio as prognostic factor for survival in rectal adenocarcinoma: A retrospective cohort study.
Scheer R; Baidoshvili A; Zoidze S; Elferink MAG; Berkel AEM; Klaase JM; van Diest PJ
World J Gastrointest Oncol; 2017 Dec; 9(12):466-474. PubMed ID: 29290917
[TBL] [Abstract][Full Text] [Related]
14. Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJC; Backes Y; Elias SG; Seerden TCJ; Schwartz MP; Spanier BWM; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JMJ; Groen JN; Borg FT; Wolfhagen FHJ; Seldenrijk CA; Raicu MG; Milne AN; van Lent AUG; Brosens LAA; Johan A Offerhaus G; Siersema PD; Tollenaar RAEM; Hardwick JCH; Hawinkels LJAC; Moons LMG; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2021 Feb; ():. PubMed ID: 33566452
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of tumour-stroma ratio in endometrial carcinoma.
Panayiotou H; Orsi NM; Thygesen HH; Wright AI; Winder M; Hutson R; Cummings M
BMC Cancer; 2015 Dec; 15():955. PubMed ID: 26674153
[TBL] [Abstract][Full Text] [Related]
16. Uniform Noting for International Application of the Tumor-Stroma Ratio as an Easy Diagnostic Tool: Protocol for a Multicenter Prospective Cohort Study.
Smit M; van Pelt G; Roodvoets A; Meershoek-Klein Kranenbarg E; Putter H; Tollenaar R; van Krieken JH; Mesker W
JMIR Res Protoc; 2019 Jun; 8(6):e13464. PubMed ID: 31199317
[TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma ratio has poor prognostic value in non-pedunculated T1 colorectal cancer: A multi-centre case-cohort study.
Dang H; van Pelt GW; Haasnoot KJ; Backes Y; Elias SG; Seerden TC; Schwartz MP; Spanier BW; de Vos Tot Nederveen Cappel WH; van Bergeijk JD; Kessels K; Geesing JM; Groen JN; Ter Borg F; Wolfhagen FH; Seldenrijk CA; Raicu MG; Milne AN; van Lent AU; Brosens LA; Offerhaus GJA; Siersema PD; Tollenaar RA; Hardwick JC; Hawinkels LJ; Moons LM; Lacle MM; Mesker WE; Boonstra JJ;
United European Gastroenterol J; 2020 Nov; 9(4):2050640620975324. PubMed ID: 33210982
[TBL] [Abstract][Full Text] [Related]
18. Tumour-stroma ratio (TSR) in breast cancer: comparison of scoring core biopsies versus resection specimens.
Karancsi Z; Hagenaars SC; Németh K; Mesker WE; Tőkés AM; Kulka J
Virchows Arch; 2023 May; ():. PubMed ID: 37198327
[TBL] [Abstract][Full Text] [Related]
19. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
20. The intra-tumoural stroma in patients with breast cancer increases with age.
Vangangelt KMH; Kramer CJH; Bastiaannet E; Putter H; Cohen D; van Pelt GW; Rakha EA; Green AR; Tollenaar RAEM; Mesker WE
Breast Cancer Res Treat; 2020 Jan; 179(1):37-45. PubMed ID: 31535319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
